Electrification And Automation Will Reshape Global Smart Manufacturing

Key Takeaways

• Strategic growth in the medical segment, automation, and vertical integration are expected to deliver outsized revenue gains and lasting margin expansion.
  
• Diversified end markets, advanced manufacturing capabilities, and a resilient global footprint strongly position Kimball for superior growth and contract wins despite cyclical headwinds.
  
• Heavy reliance on a few customers, rising global trade barriers, technology gaps, regulatory costs, and industry commoditization threaten profitability and long-term growth prospects.

Catalysts

Engages in the provision of electronics manufacturing, engineering, and supply chain support services to customers in the automotive, medical, and industrial end markets.

• Analyst consensus highlights the strategic focus on the Medical CMO as a revenue driver, but this could be significantly understated-Kimball's new Indianapolis facility offers well over half a billion dollars in potential annual revenue, and its leadership in full final assembly for a major medical customer could propel the Medical segment to outpace company-wide growth expectations, thus unlocking outsized top line growth over time.
  
• While analysts broadly agree on margin growth through restructuring and cost base optimization, they may be underestimating the long-term impact of automation and vertical integration in the new medical business; high automation and increasing production scale should drive substantial, persistent margin expansion, transforming adjusted operating income well above current historical levels.
  
• Kimball's diversification across automotive, industrial, and public safety segments positions it to capture strong multi-year growth from both the electrification of transportation and the global shift toward smart infrastructure, supporting revenue stabilization in downturns and superior growth rates as secular tailwinds drive new contract wins.
  
• With the rising digitalization of manufacturing, Kimball's early investments in advanced, high-complexity electronics assembly and its industry leadership in life-critical "5 9s" reliability provide a clear advantage in securing next-generation Industry 4.0 and IoT contracts, fueling recurring high-margin earnings streams.
  
• Industry-wide shifts toward greater nearshoring and supply chain resilience favor Kimball's global, flexible footprint, making it likely to be a preferred partner for OEMs seeking reliability and proximity, which should enable significant new contract volume wins and further boost both top-line revenue and earnings visibility in the coming years.

Kimball Electronics Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more optimistic perspective on Kimball Electronics compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
• The bullish analysts are assuming Kimball Electronics's revenue will grow by 2.3% annually over the next 3 years.
• The bullish analysts assume that profit margins will increase from 1.6% today to 3.2% in 3 years time.
• The bullish analysts expect earnings to reach $49.9 million (and earnings per share of $1.91) by about April 2029, up from $24.1 million today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $39.0 million.
• In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 22.9x on those 2029 earnings, down from 27.3x today. This future PE is lower than the current PE for the US Electronic industry at 27.9x.
• The bullish analysts expect the number of shares outstanding to decline by 0.68% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 9.1%, as per the Simply Wall St company report.

Risks

• Kimball Electronics' dependence on a concentrated base of OEM customers, especially major programs like the recently secured sole-source respiratory care final assembly, creates significant vulnerability to customer loss or renegotiation of terms, which could negatively impact future revenues and earnings stability.
  
• The long-term trend of increasing global protectionism and trade tensions poses a risk to cross-border operations, and while management claims tariff costs can be passed through, persistent trade disruptions or shifting policies could raise supply chain costs or limit market access, leading to lower net margins.
  
• The company acknowledges substantial investments are needed in automation and advanced manufacturing, but if Kimball fails to keep pace with more technologically advanced EMS rivals or underinvests in automation at new facilities, it could face operational inefficiencies and declining net margins.
  
• Heightened regulatory scrutiny and environmental compliance requirements in electronics manufacturing could lead to rising costs, especially as Kimball expands its medical CMO operations and invests in new facilities, potentially pressuring gross margins and requiring higher capital expenditures.
  
• The continued commoditization of EMS and potential industry shifts, such as large OEMs bringing manufacturing in-house, may further increase pricing pressure and reduce Kimball Electronics' ability to maintain gross margins and top-line growth over the long term.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bullish price target for Kimball Electronics is $37.0, which represents up to two standard deviations above the consensus price target of $33.0. This valuation is based on what can be assumed as the expectations of Kimball Electronics's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $37.0, and the most bearish reporting a price target of just $30.0.
• In order for you to agree with the more bullish analyst cohort, you'd need to believe that by 2029, revenues will be $1.6 billion, earnings will come to $49.9 million, and it would be trading on a PE ratio of 22.9x, assuming you use a discount rate of 9.1%.
• Given the current share price of $27.17, the analyst price target of $37.0 is 26.6% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.